Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Myelodysplastic Syndromes 11Multiple Myeloma 11Lymphoma, Non-Hodgkin 11Hodgkin Disease 11Leukemia, Lymphocytic, Chronic, B-Cell 9Hematologic Neoplasms 9Myeloproliferative Disorders 8Leukemia, Myelomonocytic, Chronic 8Lymphoma, Mantle-Cell 7Leukemia 7Lymphoma, Follicular 6Lymphoma 6Lymphoma, B-Cell, Marginal Zone 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Leukemia, Biphenotypic, Acute 5Waldenstrom Macroglobulinemia 4Lymphoma, Large B-Cell, Diffuse 4Leukemia, Myeloid, Accelerated Phase 4Carcinoma, Renal Cell 4Burkitt Lymphoma 4Anemia, Refractory, with Excess of Blasts 4Anemia, Aplastic 4Lymphoma, T-Cell, Cutaneous 3Lymphoma, Large-Cell, Immunoblastic 3Leukemia, Myeloid, Chronic-Phase 3Congenital Abnormalities 3Blast Crisis 3Thrombocythemia, Essential 2

Interventions

Peripheral Blood Stem Cell Transplantation 2fludarabine phosphate 1alethine 1Whole-Body Irradiation 1Phenytoin 1Mycophenolic Acid 1Methotrexate 1KW-2478 1Ifosfamide 1Hsp90 inhibitor KU757 1Granulocyte Colony-Stimulating Factor 1Docetaxel 1Cyclosporine 1Carboplatin 1Busulfan 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Monoclonal Gammopathy of Undetermined Significance × Whole-Body Irradiation × Clear all
NCT00245037 2017-09-27

Bu Flu TBI

OHSU Knight Cancer Institute

Phase 1/2 Completed
147 enrolled 19 charts
DermatologicLymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Immunoglobulin Light-chain Amyloidosis, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Precancerous Conditions, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡